Leo Qian

Company: Entrada Therapeutics

Job title: Co-Founder & Vice President - Discovery Research

Seminars:

1:00 pm Workshop C: Harnessing ASO & siRNA Innovation for Cell Specific Delivery & Distribution 1:00 pm

Oligonucleotide therapeutics offer a powerful approach to modulating gene expression in the CNS, but precise cell-type targeting and broad distribution, remain key challenges. This workshop will explore how different oligonucleotide modalities, siRNA, ASOs, and aptamers, can be optimized for CNS penetration, cell-specific uptake, and long-lasting efficacy. Join this session to: Understand how oligonucleotide stability and…Read more

day: Pre-Conference Workshop Day - Track A P2